Trial Profile
Postmarketing Clinical Study of Ipragliflozin - Double-blind, Parallel-group Study in Combination With Insulin in Patients With Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ipragliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms IOLITE
- Sponsors Astellas Pharma
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association
- 15 Jan 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Jan 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.